Research & Development

任你操在线精品视频不一样的视频网站助国有企业迸发能量 减税降费便利又给力


  “哈哈哈,雲侯所言甚是,微臣也有同感,如今,微臣家中已經打造了六百套鎖鏈,正好拿來鎖住猛虎!”   當鴻臚寺卿將承認李陵為李氏家主並繼承李廣爵位的文書送到李陵手里的時候,彭氏看雲瑯跟曹襄的目光才顯得溫和一些。任你操   狗子同樣咬著牙道︰“我不會認輸的,只要他打不死我,我就一定會打回來!”在线精品视频   長平重新端起一杯酒道︰“跑了也是我兒子。”不一样的视频网站   “你是說我們都是侯爵,我們兩的儀仗不一樣?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo